Augustine Therapeutics

Leuven, Belgium · Founded 2019 · Privately Held (backing)

Developer of therapeutic drugs designed to treat neuromuscular and neurodegenerative diseases. Augustine Therapeutics is based in Leuven, Belgium and was founded in 2019. Its last reported valuation was $73.5 million in Mar 2025. It has raised $93.4 million.

Last reported valuation

$73.5M

Oct 2026

Priced at

—

Total raised

$93.4M

Last round

—

How much has Augustine Therapeutics raised?

$93.4Macross 0 recorded rounds

Free account

More of Augustine Therapeutics with a free account

·The complete investor list: 14 names
·Watch Augustine Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Augustine Therapeutics investors

14 investors are on record for Augustine Therapeutics, including Novo Holdings, Participatiemaatschappij Vlaanderen, Asabys Partners and Eli Lilly and Company Foundation.

For fundraisers

Raising for a company like Augustine Therapeutics?

14 investors have backed Augustine Therapeutics.

See all 14 investors →

Frequently asked about Augustine Therapeutics

How much has Augustine Therapeutics raised?: Augustine Therapeutics has raised $93.4M in total across 0 recorded funding rounds.